Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis76
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization73
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis53
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?43
Thrombin: A Pivotal Player in Hemostasis and Beyond42
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis34
The Role of Fibrin(ogen) in Wound Healing and Infection Control32
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se31
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)31
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature30
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx30
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease27
Mean Platelet Volume Predicts Severe COVID-19 Illness24
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan22
The Role of Red Blood Cells in Hemostasis22
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage21
Platelet Activation and Thrombosis in COVID-1921
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More21
Snake Venoms in Diagnostic Hemostasis and Thrombosis20
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study20
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis20
Mutations Accounting for Congenital Fibrinogen Disorders: An Update20
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-1919
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series19
Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study19
The More Recent History of Hemophilia Treatment19
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations19
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review19
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study18
Advances in the Management of Cancer-Associated Thrombosis18
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature18
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-1918
Platelet Function in Viral Immunity and SARS-CoV-2 Infection17
Fibrinolysis in Patients with Liver Disease17
Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review17
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis17
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness17
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review16
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II16
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis16
Solid Phase Assays for Antiphospholipid Antibodies15
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III15
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis15
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives15
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians14
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches14
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments14
Thrombin Generation in Patients with Coronavirus Disease 201914
Fibrinolysis in Acute and Chronic Cardiovascular Disease14
Testing for Lupus Anticoagulants14
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data13
Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis13
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-1913
Platelet Function Testing: Update and Future Directions13
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review13
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review13
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis13
Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets13
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation12
Current Challenges in the Peripartum Management of Women with von Willebrand Disease12
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years12
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience12
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications12
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part I12
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles12
Gene Therapy for Inherited Bleeding Disorders12
Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment11
Impaired Fibrinolysis in the Antiphospholipid Syndrome11
Mechanisms of Bone Remodeling Disorder in Hemophilia11
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies11
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives11
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties11
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review11
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism11
The Art and Science of Building a Computational Model to Understand Hemostasis11
ROTEM Testing for Direct Oral Anticoagulants11
The Biological Significance of von Willebrand Factor O-Linked Glycosylation11
Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism11
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review11
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II11
Fibrinolysis in Venous Thromboembolism10
Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial10
The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review10
Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?10
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review10
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment10
Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations10
Venous Thromboembolism among Critically Ill Children: A Narrative Review10
Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized Controlled Trials10
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV10
One Hundred Years of Congenital Fibrinogen Disorders10
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan9
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond9
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia9
Heparin: The Journey from Parenteral Agent to Nasal Delivery9
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-199
Cancer-Associated Splanchnic Vein Thrombosis9
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation9
Altered Fibrinolysis during and after Surgery9
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms9
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger9
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review9
Viscoelastic Testing in the Management of Adult Patients on Mechanical Circulatory Support Devices with Focus on Extracorporeal Membrane Oxygenation8
Altered Fibrinolysis in Hematological Malignances8
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease8
Right Atrial Thrombosis and Pulmonary Embolism: A Narrative Review8
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties8
Cerebral Venous Thrombosis8
The Current Role of Platelet Function Testing in Clinical Practice8
2021 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles8
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding8
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations8
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders8
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease8
Heparan Sulfate Proteoglycans in Diabetes8
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III8
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles8
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment8
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade8
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients8
Thrombin Generation Markers as Predictors of Cancer-Associated Venous Thromboembolism: A Systematic Review7
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System7
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards7
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art7
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition7
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study7
The Role of Epigenetics in the Regulation of Hemostatic Balance7
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding—A Systematic Review and a Cohort Study7
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?7
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19)7
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice7
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention7
The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review7
Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review7
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*7
Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter—A Systematic Review and Meta-analysis7
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings7
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review7
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles7
Clot Waveform Analysis for Monitoring Hemostasis7
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology7
0.057354927062988